Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayata, Y
Right arrow Articles by Takizawa, N
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hayata, Y
Right arrow Articles by Takizawa, N

Chest, Vol 81, 269-277, Copyright © 1982 by American College of Chest Physicians

ARTICLES

Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer

Y Hayata, H Kato, C Konaka, J Ono and N Takizawa

Photoradiation therapy (PRT) was performed in 13 lung cancer cases and in one case of severely atypical squamous metaplasia following administration of hematoporphyrin derivative (HpD). The HpD is activated by visible red light (630 nm, 90 to 400 mW) from an argon dye laser. The cytocidal effects were due to the activation of the HpD, since 400 mW of power has in itself no effect on normal epithelium, even with long-term exposure. HpD is retained longer by malignant tissue than by normal tissue. Therefore, the lesions were irradiated with the red laser beam, delivered by a quartz fiber inserted through the instrumentation channel of the fiberoptic bronchoscope, 48 hours or more after intravenous injection of 2.5 to 4.0 mg/kg of HpD. A total of 14 cases received PRT. In one, two small, smooth-surfaced, squamous cell carcinoma tumors in the right B2b of a 74-year-old man who had refused surgery disappeared three days after HpD-photoradiation, and the patient remained disease-free 16 months after the treatment. In 12 cases of centrally located lung cancer local effects were obtained in all. However, there was no significant improvement in survival, attributable to the fact that all were advanced-stage cases. One patient with severely atypical squamous metaplasia requested treatment, and complete disappearance of metaplastic atypic was obtained.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
J-M. Vergnon, R. M. Huber, and K. Moghissi
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers.
Eur. Respir. J., July 1, 2006; 28(1): 200 - 218.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Furukawa, H. Kato, C. Konaka, T. Okunaka, J. Usuda, and Y. Ebihara
Locally Recurrent Central-Type Early Stage Lung Cancer < 1.0 cm in Diameter After Complete Remission by Photodynamic Therapy
Chest, November 1, 2005; 128(5): 3269 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. N. Mathur, E. Edell, T. Sutedja, and J.-M. Vergnon
Treatment of Early Stage Non-small Cell Lung Cancer
Chest, January 1, 2003; 123(1_suppl): 176S - 180S.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. S. McCaughan Jr. and T. E. Williams
PHOTODYNAMIC THERAPY FOR ENDOBRONCHIAL MALIGNANT DISEASE: A PROSPECTIVE FOURTEEN-YEAR STUDY
J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 940 - 947.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
S. Murakami, Y. Watanabe, H. Saitoh, R. Yamashita, J. Shimizu, M. Oda, and Y. Hayashi
Treatment of Multiple Primary Squamous Cell Carcinomas of the Lung
Ann. Thorac. Surg., October 1, 1995; 60(4): 964 - 969.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American College of Chest Physicians.